Bloomage Biotechnology: Controlling Shareholder Has Increased Holdings by 2.1177 Million Shares, Completing Over Half of Share Increase Plan

Deep News08-29

Key Points of Bloomage Biotechnology Corporation Limited's Controlling Shareholder Share Increase Progress Announcement

**Basic Information of Share Increase Plan** - Increasing entity: Controlling shareholder Huaxi Xinyu Investment Co., Ltd. - Increase period: August 8, 2025 to February 7, 2026 (6 months) - Increase amount: 200-300 million yuan - Increase ratio: Not exceeding 1% of total share capital - Increase price: Not exceeding 70 yuan per share

**Latest Share Increase Progress** - Implementation period: August 27-29, 2025 - Shares increased: 2.1177 million shares, accounting for 0.44% of total share capital - Amount invested: 122 million yuan - Completion progress: Has exceeded 50% of the minimum 200 million yuan plan

**Controlling Shareholder Holdings** - Holdings before increase: 283.5 million shares, accounting for 58.86% - Combined holdings of parties acting in concert: 285 million shares, accounting for 59.17% - Actual controller: Chairman and General Manager Zhao Yan

**Future Arrangements** The share increase plan has not been completed and will continue to be implemented as planned, using the company's own funds or self-raised funds for subsequent purchases.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1188552554?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-29 20:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1188552554","market":"us","top_or_hot":-1,"title":"Bloomage Biotechnology: Controlling Shareholder Has Increased Holdings by 2.1177 Million Shares, Completing Over Half of Share Increase Plan","media":"Deep News","content":"<p>Key Points of Bloomage Biotechnology Corporation Limited's Controlling Shareholder Share Increase Progress Announcement</p>\n<p>**Basic Information of Share Increase Plan**\n- Increasing entity: Controlling shareholder Huaxi Xinyu Investment Co., Ltd.\n- Increase period: August 8, 2025 to February 7, 2026 (6 months)\n- Increase amount: 200-300 million yuan\n- Increase ratio: Not exceeding 1% of total share capital\n- Increase price: Not exceeding 70 yuan per share</p>\n<p>**Latest Share Increase Progress**\n- Implementation period: August 27-29, 2025\n- Shares increased: 2.1177 million shares, accounting for 0.44% of total share capital\n- Amount invested: 122 million yuan\n- Completion progress: Has exceeded 50% of the minimum 200 million yuan plan</p>\n<p>**Controlling Shareholder Holdings**\n- Holdings before increase: 283.5 million shares, accounting for 58.86%\n- Combined holdings of parties acting in concert: 285 million shares, accounting for 59.17%\n- Actual controller: Chairman and General Manager Zhao Yan</p>\n<p>**Future Arrangements**\nThe share increase plan has not been completed and will continue to be implemented as planned, using the company's own funds or self-raised funds for subsequent purchases.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bloomage Biotechnology: Controlling Shareholder Has Increased Holdings by 2.1177 Million Shares, Completing Over Half of Share Increase Plan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBloomage Biotechnology: Controlling Shareholder Has Increased Holdings by 2.1177 Million Shares, Completing Over Half of Share Increase Plan\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2025-08-29 20:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Key Points of Bloomage Biotechnology Corporation Limited's Controlling Shareholder Share Increase Progress Announcement</p>\n<p>**Basic Information of Share Increase Plan**\n- Increasing entity: Controlling shareholder Huaxi Xinyu Investment Co., Ltd.\n- Increase period: August 8, 2025 to February 7, 2026 (6 months)\n- Increase amount: 200-300 million yuan\n- Increase ratio: Not exceeding 1% of total share capital\n- Increase price: Not exceeding 70 yuan per share</p>\n<p>**Latest Share Increase Progress**\n- Implementation period: August 27-29, 2025\n- Shares increased: 2.1177 million shares, accounting for 0.44% of total share capital\n- Amount invested: 122 million yuan\n- Completion progress: Has exceeded 50% of the minimum 200 million yuan plan</p>\n<p>**Controlling Shareholder Holdings**\n- Holdings before increase: 283.5 million shares, accounting for 58.86%\n- Combined holdings of parties acting in concert: 285 million shares, accounting for 59.17%\n- Actual controller: Chairman and General Manager Zhao Yan</p>\n<p>**Future Arrangements**\nThe share increase plan has not been completed and will continue to be implemented as planned, using the company's own funds or self-raised funds for subsequent purchases.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0229","symbol_name":"化学制品","start_time":0,"source_url":"","article_id":"1188552554","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1188552554","pubTimestamp":1756470148,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"Key Points of Bloomage Biotechnology Corporation Limited's Controlling Shareholder Share Increase Progress Announcement **Basic Information of Share Increase Plan** - Increasing entity: Controlling...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"688363":"华熙生物","BK0229":"化学制品","BK0239":"医药制造"},"translate_title":"华熙生物：控股股东累计增持211.77万股增持计划完成过半","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688363":1},"content_text":"Key Points of Bloomage Biotechnology Corporation Limited's Controlling Shareholder Share Increase Progress Announcement\n**Basic Information of Share Increase Plan**\n- Increasing entity: Controlling shareholder Huaxi Xinyu Investment Co., Ltd.\n- Increase period: August 8, 2025 to February 7, 2026 (6 months)\n- Increase amount: 200-300 million yuan\n- Increase ratio: Not exceeding 1% of total share capital\n- Increase price: Not exceeding 70 yuan per share\n**Latest Share Increase Progress**\n- Implementation period: August 27-29, 2025\n- Shares increased: 2.1177 million shares, accounting for 0.44% of total share capital\n- Amount invested: 122 million yuan\n- Completion progress: Has exceeded 50% of the minimum 200 million yuan plan\n**Controlling Shareholder Holdings**\n- Holdings before increase: 283.5 million shares, accounting for 58.86%\n- Combined holdings of parties acting in concert: 285 million shares, accounting for 59.17%\n- Actual controller: Chairman and General Manager Zhao Yan\n**Future Arrangements**\nThe share increase plan has not been completed and will continue to be implemented as planned, using the company's own funds or self-raised funds for subsequent purchases.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1188552554","isCrawlerRequest":true}